These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32242499)

  • 21. Synthesis and catalytic antibody functionalization of dendrimers.
    Córdova A; Janda KD
    J Am Chem Soc; 2001 Aug; 123(34):8248-59. PubMed ID: 11516276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalytic antibody route to the naturally occurring epothilones: total synthesis of epothilones A-F.
    Sinha SC; Sun J; Miller GP; Wartmann M; Lerner RA
    Chemistry; 2001 Apr; 7(8):1691-702. PubMed ID: 11349910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly sensitive and rapid detection of antibody catalysis by luminescent bacteria.
    Shulman H; Eberhard A; Eberhard C; Ulitzur S; Keinan E
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2353-6. PubMed ID: 11055354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis.
    Zhu X; Tanaka F; Hu Y; Heine A; Fuller R; Zhong G; Olson AJ; Lerner RA; Barbas CF; Wilson IA
    J Mol Biol; 2004 Nov; 343(5):1269-80. PubMed ID: 15491612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.
    Wagner J; Lerner RA; Barbas CF
    Science; 1995 Dec; 270(5243):1797-800. PubMed ID: 8525368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herbicide-resistance conferred by expression of a catalytic antibody in Arabidopsis thaliana.
    Weiss Y; Shulman A; Ben Shir I; Keinan E; Wolf S
    Nat Biotechnol; 2006 Jun; 24(6):713-7. PubMed ID: 16751769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of the aldolase antibody-derived chemical-antibodies targeting α5β1 integrin.
    Goswami RK; Liu Y; Liu C; Lerner RA; Sinha SC
    Mol Pharm; 2013 Feb; 10(2):538-43. PubMed ID: 23102054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab.
    Sinha SC; Li LS; Miller GP; Dutta S; Rader C; Lerner RA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3095-9. PubMed ID: 14981258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.
    Abraham S; Guo F; Li LS; Rader C; Liu C; Barbas CF; Lerner RA; Sinha SC
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5584-9. PubMed ID: 17372220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.
    Shamis M; Lode HN; Shabat D
    J Am Chem Soc; 2004 Feb; 126(6):1726-31. PubMed ID: 14871103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic Enantioselective Retro-Aldol Reactions: Kinetic Resolution of β-Hydroxyketones with Aldolase Antibodies.
    Zhong G; Shabat D; List B; Anderson J; Sinha SC; Lerner RA; Barbas Iii CF
    Angew Chem Int Ed Engl; 1998 Oct; 37(18):2481-2484. PubMed ID: 29711357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.
    Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA
    Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A catalytic antibody produces fluorescent tracers of gap junction communication in living cells.
    Subauste MC; List B; Guan X; Hahn KM; Lerner R; Gilula NB
    J Biol Chem; 2001 Dec; 276(52):49164-8. PubMed ID: 11606573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in abzyme studies.
    Suzuki H
    J Biochem; 1994 Apr; 115(4):623-8. PubMed ID: 8089074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies toward the duocarmycin prodrugs for the antibody prodrug therapy approach.
    Li LS; Sinha SC
    Tetrahedron Lett; 2009 Jun; 50(24):2933-2935. PubMed ID: 20160897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antibody catalysis route to the total synthesis of epothilones.
    Sinha SC; Barbas CF; Lerner RA
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14603-8. PubMed ID: 9843936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A QM/MM study on the origin of retro-aldolase activity of a catalytic antibody.
    De Raffele D; Martí S; Moliner V
    Chem Commun (Camb); 2021 May; 57(43):5306-5309. PubMed ID: 33912877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broadening the Aldolase Catalytic Antibody Repertoire by Combining Reactive Immunization and Transition State Theory: New Enantio- and Diastereoselectivities.
    Zhong G; Lerner RA; Barbas III
    Angew Chem Int Ed Engl; 1999 Dec; 38(24):3738-3741. PubMed ID: 10649343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.